Understanding the attitudes of the elderly towards enrolment into cancer clinical trials.
about
Can we predict toxicity and efficacy in older patients with cancer? Older patients with colorectal cancer as an examplePrincipal components analysis to identify influences on research communication and engagement during an environmental disasterParticipation in Clinical Research Registries: A Focus Group Study Examining Views From Patients With Arthritis and Other Chronic Illnesses.Participation of older newly-diagnosed cancer patients in an observational prospective pilot study: an example of recruitment and retentionWhat leads Indians to participate in clinical trials? A meta-analysis of qualitative studiesResearch participation among older adults with mobility limitation.Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendationsAge disparity in the dissemination of imatinib for treating chronic myeloid leukemiaExclusion of older patients from ongoing clinical trials for hematological malignancies: an evaluation of the National Institutes of Health Clinical Trial Registry.Evaluation of patient enrollment in oncology phase I clinical trials.Participation and survival of geriatric patients in Phase I clinical trials: the Karmanos Cancer Institute (KCI) experienceBarriers to recruitment of rural patients in cancer clinical trials.External validity of a trial comprised of elderly patients with hormone receptor-positive breast cancer.Assessment of perceived cost to the patient and other barriers to clinical trial participation.A multicenter retrospective study on clinical characteristics, treatment patterns, and outcome in elderly patients with hepatocellular carcinoma.Perceptions of Cancer Clinical Research Among African American Men in North Carolina.Motivations for (non)participation in population-based health studies among the elderly - comparison of participants and nonparticipants of a prospective study on influenza vaccination.Outcome of active anti-cancer treatment in elderly patients with advanced non-small cell lung cancer: A single center experience.Integrated oncogeriatric approach: a systematic review of the literature using concept analysisPhase I trial outcomes in older patients with advanced solid tumoursTolerance to chemotherapy in elderly patients with cancer.Barriers to enrollment of elderly adults in early-phase cancer clinical trials.EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population.Management of elderly patients with primary central nervous system lymphoma.First-line treatment of newly diagnosed elderly patients with chronic myeloid leukemia: current and emerging strategies.Participation of the elderly population in clinical trials: barriers and solutions.A review of the management of elderly patients with non-small-cell lung cancer.Of Guinea pigs and gratitude: the difficult discourse of clinical trials from the cancer patient perspective.Why take part in personalised cancer research? Patients' genetic misconception, genetic responsibility and incomprehension of stratification-an empirical-ethical examination.Representation of the elderly in trials of laparoscopic surgery for colorectal cancer.Attitudes of older adults to their participation in clinical trials: a pilot study.Attitudes toward participating in Phase I clinical trials: an investigation with patient-family-physician triads.Participation of elderly patients in registration trials for oncology drug applications in Japan.Management of elderly patients with advanced non-small cell lung cancer: a single-center experience.Meeting the needs of the aging population: the Canadian Network on Aging and Cancer—report on the first Network meeting, 27 April 2016.Learning from older peoples' reasons for participating in demanding, intensive epidemiological studies: a qualitative study.End-stage renal disease and recruitment to randomized trials: why is it so difficult? Results from a survey among Norwegian nephrologists.Key issues for elderly patients contemplating clinical trial participation.The comprehensive geriatric assessment in oncology: promises, pitfalls, and practicalities.Disparate inclusion of older adults in clinical trials: priorities and opportunities for policy and practice change.
P2860
Q28069620-F8600028-3DE4-441E-8065-F58CDAC28A6BQ28386712-C681CC2C-68E4-4CDB-8ADF-98C301A6AA5EQ30488431-38BB2DA6-BA40-4649-9034-6EA56056D5C5Q33491875-A4C2DA89-D9C2-4D0F-8D9E-9FD0E58B38DEQ33588531-DFEAA6BB-86C1-4224-950D-2FAC670B7769Q33673916-99852778-F460-4BDD-AC32-03608C1BABABQ34031134-75868301-FD3F-4E9C-80DB-BEF53738509EQ34032508-33C37C8E-2669-468D-BB88-C4D79421A9D0Q34359352-DA32ECFA-D135-4916-80FE-8C1509F7C691Q34594562-B35A05C8-581C-4882-B3BD-A08B8EE26159Q34801461-FECCB7D2-3E24-4411-A8FB-86D0DBF0BA8DQ34974911-6E339A06-D4CC-4629-A398-99AB51EFF9E7Q35125211-601C3720-3A64-43BA-9278-37558FDF3002Q35205695-5B804C0E-0035-429A-9A28-C02D559A827DQ35584505-C5F8421C-714D-42F8-88A9-03A96AAA075DQ35771316-0B0C0840-3F99-4BA7-AC6F-9B17E5FC1331Q36266649-F1C99F0F-B1A0-4BB3-A48D-2EAAE58837B3Q36439388-A2709A49-E866-445B-AD29-2D43A2F84A47Q36496794-10127ECA-6C74-4655-AF8A-3E4F4AFADB96Q36547934-04ABB3AE-6C50-474A-A64E-574BB20D7DD5Q36715266-31A95618-CA05-45E8-9C62-2DB77D91EDEEQ37476974-84612ACB-ADD6-451D-8EE9-115DD462DBD3Q37589341-0E89E72F-09D3-4B23-AF84-1627BA27ECE7Q38096927-F2219791-8508-43C4-BD89-656BC3B82463Q38202913-29E75C7B-6B5E-4B02-AE94-D6E1199981C5Q38222467-3A9B1628-7B53-4725-ADDC-57BA232A4062Q38233740-00099DE8-E885-4708-A919-424FDF91A592Q38565437-FE132BA0-A88D-4333-BC90-65D4DAC16C66Q38832807-8F8335F2-9543-43DB-B2CD-85FBF0270B39Q39110238-35FA6006-7BA9-4BF7-9D30-EAEF2484F7F2Q39232697-B954243F-7F4B-4DE6-B070-6840BD4E87ECQ40563636-2BE5DE68-6C39-43D6-B9EF-37A440B057BFQ44107623-8C806515-B007-43CA-98B0-A75BA18C5F5EQ44244242-2C3E9DB0-EFC1-47C4-86C9-BD1065CCF568Q45940625-1C2CF021-E652-4348-B21C-72A18ECF9512Q47162752-4CCEFA9B-B57A-46DF-91DF-C43E03854F48Q47305751-67E6A59E-6AC1-4C8C-947C-993C541C7822Q47435057-380258E4-9506-462B-BE7C-487DC872290CQ51835491-8A86613F-E738-475F-B5EF-007335F880E8Q53064501-AEC54BAE-0A85-4C76-A346-7BD78DA79692
P2860
Understanding the attitudes of the elderly towards enrolment into cancer clinical trials.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Understanding the attitudes of the elderly towards enrolment into cancer clinical trials
@nl
Understanding the attitudes of the elderly towards enrolment into cancer clinical trials.
@ast
Understanding the attitudes of the elderly towards enrolment into cancer clinical trials.
@en
type
label
Understanding the attitudes of the elderly towards enrolment into cancer clinical trials
@nl
Understanding the attitudes of the elderly towards enrolment into cancer clinical trials.
@ast
Understanding the attitudes of the elderly towards enrolment into cancer clinical trials.
@en
prefLabel
Understanding the attitudes of the elderly towards enrolment into cancer clinical trials
@nl
Understanding the attitudes of the elderly towards enrolment into cancer clinical trials.
@ast
Understanding the attitudes of the elderly towards enrolment into cancer clinical trials.
@en
P2093
P2860
P3181
P356
P1433
P1476
Understanding the attitudes of the elderly towards enrolment into cancer clinical trials.
@en
P2093
Carol A Townsley
Christine Marquez
Gregory R Pond
Kelvin K Chan
Lillian L Siu
P2860
P2888
P3181
P356
10.1186/1471-2407-6-34
P407
P577
2006-02-08T00:00:00Z
P5875
P6179
1020245788